Trends in Manufacturing eBook
Pharmaceutical Technology's Trends in Manufacturing eBook
Read the article:
Read the eBook:
|Articles|May 15, 2022
- Pharmaceutical Technology, Trends in Manufacturing, May 2022
- Volume 2022 eBook
- Issue 2
- Pages: 58-59
Embracing New Realities
Author(s)Grant Playter
Virtual and augmented reality have emerged as critical digital training tools.
Advertisement
While a conclusive ‘end’ to the pandemic remains elusive, the transition to a post-pandemic economic model has been defined by a mass ramp-up of various means of digital communication. Digital training tools are one such solution, often allowing companies to effectively prepare employees for the job before they even set foot on-site. While these tools can take on many forms, of particular prominence are augmented reality (AR) and virtual reality (VR) visualization technologies.
Read this article in
About the authors
Grant Playter is the Assistant Editor at Pharmaceutical Technology.
Article details
Pharmaceutical Technology
eBook: Trends in Manufacturing
May 2022
Pages: 58–59
Citation
When referring to this article, please cite it as G. Playter, "Embracing New Realities," Pharmaceutical Technology's Trends in Manufacturing eBook (May 2022).
Articles in this issue
over 4 years ago
Demonstrating a Fully Continuous Bioprocessover 4 years ago
Manufacturing OSD Forms: Key Trends Shaping the Industryover 4 years ago
Don’t Gamble on Tablet Tooling Maintenanceover 4 years ago
Implementing Continuous Bioprocessing: From Theory to Practiceover 4 years ago
Plan Early: Optimizing Stability During LyophilizationAdvertisement
Related to this article
Vibha Jawa, PhD, chief scientific officer at EpiVax, explains why the need for animal studies varies by modality and what it takes for organ-on-chip and other human-relevant models to replace these studies in IND-enabling toxicology work.
Sanjay Konagurthu, PhD, senior director of Science and Innovation at Thermo Fisher Scientific, explains what teams need to do to ensure the usefulness of AI and what strides have been made with AI in regulatory submissions.
Pauric Bannigan, Intrepid Labs, explains where AI speeds formulation decisions, why data is the bottleneck, and how active learning trains models with far less data.
The new initiative aims to apply traceable AI and science to expand care worldwide by translating discovery into tools that accelerate drug development.
Sanjay Konagurthu, PhD, senior director, Science and Innovation at Thermo Fisher Scientific, provides an update on the progress of AI and machine learning used in drug delivery.
Stephanie Johnson, Pfizer, explains how off-platform triggers, single-owner risk registers, and traceable prior knowledge keep protein formulation programs on track.
Stephanie Johnson, Pfizer, discusses how platform formulations moved 2 Pfizer protein programs to IND in 8 months by redistributing, not removing risk.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Leaders Weigh in On AI's Measurable Results In 2026
2
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
3
Manufacturing Intelligence: How AI Poisoning Hides in Plain Sight
4
Why BMS, Roche, and LGM Pharma Outsourced Key Capabilities
5